Multiple Dose Vials

This page contains recent news articles, when available, and an overview of Multiple Dose Vials but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Heparin caused death, class action suit claims  -  ‎Mar 3, 2009‎
...with the use of Heparin, Baxter issued press releases regarding a voluntary recall of nine lots of Heparin Sodium Injection multiple dose vials on Jan. St. Clair Record

Guest column: Use caution: Ban mercury from flu shots for children  -  ‎Feb 25, 2009‎
...this about flu vaccines containing Thimerosal: "It's easier and cheaper to use multiple-dose vials of vaccine instead of individually packaged shots. DesMoinesRegister.com

Death factories by the dozens  -  ‎Feb 28, 2009‎
Twenty-five tonnes of scary garbage of used syringes, needles, multiple dose vials, IV sets, medicine bottles and even paediatric droppers, neatly stacked Times of India

Warehouses raided, sealed in Gujarat after hepatitis-B outbreak  -  ‎Mar 1, 2009‎
The bio-medical waste seized from the warehouses comprised syringes, multiple dose vials, IV sets, needles and medicine bottles. Thaindian.com

Heatlth and Safety Concerns Over US Imports of Chinese Products  -  Jan 29, 2009
2008, the FDA posted on its website a notice by Baxter Healthcare Corporation that it had temporarily halted the manufacture of its multiple-dose vials Right Side News,

Half-dose flu shots could help prevent shortages  -  Dec 11, 2008
Flu vaccine is commonly sold in multiple-dose vials and single-dose syringes. John Treanor, MD, of the University of Rochester, senior author of the study, CIDRAP,

Strides Arcolab receives USFDA approval for two more products ...  -  Sep 2, 2008
20mg/5 ml, 120 mg /30 ml Multiple dose Vials) and Dexamethasone Sodium Phosphate Injection USP, 10 mg /ml, (10 ml Multiple-dose Vials). Equity Bulls,

APP Pharmaceuticals Receives Final Approval for Nausea Drug  -  Jul 11, 2008
...approval from the FDA for its ANDA to market a generic version of Roche’s Kytril in 1-mg/mL, 1-mL single-dose and 1-mg/mL, 4-mL multiple-dose vials. FDA news (subscription),

APP Pharmaceuticals Receives Final Approvals for Additional ...  -  03 Jul 2008
1 mL single dose vials and will commence distributing the 1 mg/mL, 1 mL single dose, and 1mg/mL, 4 mL multiple dose vials immediately. Business Wire (press release),

FDA OKs APP Pharma's generic nausea injection  -  03 Jul 2008
The drug will be available in 1 mg/mL, 1 mL single dose, and 1mg/mL, 4mL multiple dose vials. According to IMS data, branded sales of these two doses CNNMoney.com

Teva Introduces Granisetron Hydrochloride Injection in Multiple ...  -  Jul 1, 2008
...product is AP rated to Kytril®* Injection. With the addition of this new size, Teva now offers Granisetron Hydrochloride Injection in 0.1 mg/mL, 1 mL vials, PharmaLive.com (press release),

Akorn-Strides, LLC Announces FDA Approvals for Famotidine ...  -  Jun 26, 2008
...today announced the approvals of two ANDAs for Famotidine Injection USP, 20 mg/2mL Single-Dose Vials and 40 mg/4mL & 200 mg/20mL Multiple-Dose Vials. Business Wire (press release),

FDA approves Akorn-Strides's two ANDAs for Famotidine Injection  -  Jun 26, 2008
...of two abbreviated new drug applications for Famotidine Injection USP, 20 mg/2mL single-dose vials and 40 mg/4mL and 200 mg/20mL multiple-dose vials. Trading Markets (press release),

AKRX: Joint Venture Receives FDA Approval of Two ANDAs for ...  -  Jun 26, 2008
...announced the approvals of two ANDAs for Famotidine Injection USP, 20 mg/2mL Single-Dose Vials and 40 mg/4mL & 200 mg/20mL Multiple-Dose Vials. Trading Markets (press release),

Akorn-Strides gets FDA OK for flumazenil injection USP, multiple ...  -  May 14, 2008
...has approved its abbreviated new drug application for flumazenil injection USP packaged in five milliliter and 10 milliliter multiple dose vials. Interactive Investor,

Akorn-Strides, LLC Announces FDA Approval For Flumazenil Injection ...  -  May 19, 2008
Akorn-Strides, LLC announced the approval of an ANDA for Flumazenil Injection USP, 0.1 mg/mL, packaged in 5 mL and 10 mL Multiple Dose Vials. Medical News Today (press release),

Akorn-Strides Gets FDA Approval for Flumazenil Injection  -  May 21, 2008
Akorn-Strides received an ANDA approval for Flumazenil Injection, packaged in 5-mL and 10-mL multiple-dose vials. Flumazenil Injection is indicated for the FDA news (subscription),

In a new Eye on FDA podcast, blogger Mark Senak interviews FDA ...  -  May 19, 2008
In February 2008, the FDA announced that Baxter International had temporarily stopped manufacturing multiple dose vials of heparin, a blood-thinning drug, PR Web (press release),

Small Cap Stocks to Watch - CRDN, AKRX, CUB, SINT  -  May 14, 2008
Akorn-Strides today announced the approval of an ANDA for Flumazenil Injection USP, 0.1 mg/mL, packaged in 5 mL and 10 mL Multiple Dose Vials. TransWorldNews (press release),

Market Report -- In Play (AKRX)  -  May 14, 2008
Akorn announces FDA approval for flumazenil injection USP, 0.1 mg/mL-5mL and 10 mL multiple dose vials Akorn-Strides announces the approval of an ANDA for MSN Money

Streetinvesting.com: Market Review on Akorn Inc.  -  May 14, 2008
2008, -- Akorn-Strides, LLC announced the approval of an ANDA for Flumazenil Injection USP, 0.1 mg/mL, packaged in 5 mL and 10 mL Multiple Dose Vials. Trading Markets (press release),

4 more suits filed blaming heparin for Toledo deaths  -  Apr 17, 2008
According to the suits, the Food and Drug Administration estimates more than 1 million multiple-dose vials of heparin are sold each month in the US About 50 Toledo Blade,

FDA: No Shortage of Heparin  -  Mar 24, 2008
It followed a recall in late February of Heparin in single and multiple dose vials made by Baxter Healthcare Corp. B. Braun Medical supplies 10%-15% of the WebMD

Heparin In Baxter Multiple Dose Vials In FDA Alert  -  Feb 12, 2008
If doctors can't find an effective alternative, then they should be extremely careful when using any Baxter multiple-dose vials they have, said the FDA, Medical News Today,

Baxter suspends multi-dose heparin vial production  -  Feb 11, 2008
Baxter makes about half of all multiple-dose vials of heparin sold in the United States, FDA said. Patients reported side effects that included difficulty Guardian Unlimited,

Baxter's Multiple-Dose Vial Heparin Linked to Severe Allergic ...  -  Feb 11, 2008
11, 2008--The US Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials PharmaLive.com (press release),

FDA update on heparin recall  -  Mar 2, 2008
Products affected are: Baxter’s Heparin Sodium Injection multiple-dose vials (1000 units/mL concentration, 10 mL and 30 mL vials; 5000 units/mL Food Consumer,

Baxter's Multiple-Dose Vial Heparin Linked to Severe Allergic ...  -  Feb 11, 2008
NEW YORK, NY -- February 11, 2008 -- Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of injectable heparin sodium DG News

Manufacturer Halts Production of Blood Thinner Heparin  -  Feb 11, 2008
FDA has concluded that it is better for the public health to allow the Baxter multiple dose vials of heparin to remain in distribution," Jenkins said. Forbes,

What is heparin?  -  Feb 12, 2008
These events involved multiple-dose vials. The scope: Only heparin made by Baxter International Inc. and packaged in multiple-dose vials is involved; Chicago Tribune,

Baxter Heparin Recall Demonstrates Limitations On FDA's Ability To ...  -  Mar 5, 2008
In the meantime, Baxter has temporarily suspended manufacturing its multiple-dose vials of heparin sodium. Heparin sodium is a blood thinner (anticoagulant) InjuryBoard.com,

Baxter halts Heprin production after reports of allergic reactions  -  Feb 11, 2008
The FDA concured with Baxter's decision to halt manufacture of heparin sodium in multiple-dose vials, said Dr. Janet Woodcock, FDA's deputy commissioner for Chicago Tribune,

Problems with Baxter heparin still unresolved  -  Feb 12, 2008
Deerfield, Ill - Baxter Healthcare Corporation has now temporarily stopped manufacturing multiple-dose vials of heparin because of reports of serious TheHeart.Org,

Baxter Halts Production of Multi-Use Heparin Vials  -  Feb 11, 2008
Dr. Jenkins said recalling the multiple-dose vials would create an immediate shortage of a "medically necessary product," because Baxter produces about half MedPage Today,

Baxter Healthcare temporarily halting heparin production due to ...  -  Feb 13, 2008
Reported adverse events have almost exclusively occurred in patients administered high bolus doses from multiple-dose vials. Ortho SuperSite,

FDA Probes 4 Heparin Deaths  -  Feb 11, 2008
11, 2008 -- The FDA today announced that Baxter Healthcare has temporarily stopped making multiple-dose vials of the injectable blood-thinning drug heparin WebMD

Baxter halts mulitple-dose Heprin production after reports of ...  -  Feb 11, 2008
February 11, 2008 The US Food and Drug Administration said Baxter International Inc. has temporarily stopped manufacturing "multiple dose" vials of the Chicago Tribune,

Baxter halts heparin production as adverse events shoot up  -  Feb 12, 2008
The company has stopped manufacturing multiple-dose vials of heparin due to reports of an increase in serious allergic reactions and low blood pressure in Pharma Times (subscription),

Warning about deaths and serious reactions linked to blood ...  -  Feb 13, 2008
Baxter International makes about half of all multiple-dose vials of heparin sold in the United States and millions of patients are given the product News-Medical.net,

Baxter suspends production of heparin after deaths  -  Feb 13, 2008
The US FDA has supported the decision: "FDA concurs with Baxter's decision to halt manufacture of heparin sodium in multiple-dose vials," Janet Woodcock, LabTechnologist.com,

Health panel discusses misuse of syringes  -  Feb 22, 2008
Since multiple-dose vials were the major factors in both recent cases in Nassau, Daines has asked the Food and Drug Administration to consider a full or Franklin Square/Elmont/West Hempstead Herald,

Baxter halts high dosages of heparin  -  Feb 11, 2008
Baxter agreed to temporarily halt the manufacture of the drug in the multiple-dose vials associated with the reactions, the FDA and the company said. Chicago Daily Herald,

FDA Issues Public Health Advisory for Popular Drug: Heparin  -  Feb 18, 2008
Baxter Healthcare Corporation has temporarily stopped producing multiple-dose vials of the injectable blood-thinning drug heparin. Associated Content,

Mix-Up Blamed for FDA Failure on China Heparin Plant (Update1)  -  Feb 18, 2008
Baxter, which had about half the US market, agreed last week to temporarily halt making heparin in multiple-dose vials associated with the side effects. Bloomberg

FDA Missed Heparin Plant Inspection in China  -  Feb 18, 2008
The Changzhou SPL plant in China, which makes the active ingredient in Baxter Healthcare's multiple-dose vials of heparin sodium, had not been inspected and MedPage Today,

Public Health Advisory - FDA Investigates Bad Bloodthinner  -  Feb 12, 2008
Following reports of serious allergic reactions and possibly four deaths - Baxter Healthcare has temporarily stopped making the multiple-dose vials of InjuryBoard.com,

Baxter Drug Heparin Manufacturing Halted  -  Feb 13, 2008
Boston (eCanadaNow) - The blood thinner drug Heparin has been put on hold by Baxter, as the multiple-dose vials were found to cause severe reactions in E Canada Now,

Baxter Blood Thinner Drug Heparin Put On Hold  -  Feb 12, 2008
...in the multiple-dose vials, can cause severe reactions among patients, including dropping blood pressure so low that they are at risk of going into dBTechno,

FDA Tells Doctors to Stop Use  -  Feb 11, 2008
Earlier in the day Baxter said it would stop manufacturing multiple-dose vials of its injectable heparin. Baxter last month announced the voluntary recall Wall Street Journal

National and Washington news in brief  -  Feb 19, 2008
One of its two manufacturers, Baxter International, stopped selling its multiple-dose vials of heparin earlier this month, and Monday the FDA advised San Jose Mercury News,

Controversy Veils Court’s Ruling in Autism Case  -  Mar 7, 2008
The only childhood vaccines that contain more than trace amounts of thimerosal are multiple-dose vials of some flu vaccines. eFluxMedia

Baxter Heparin Shouldn’t Be Used, FDA Warns  -  Feb 11, 2008
Just prior to the FDA warning, Baxter International had said it would stop manufacturing its multiple-dose vials of injectable heparin following reports of Newsinferno.com,

Pharma Sector: Few Newsmakers Of The Week - Inspire Pharma, Merck ...  -  Feb 15, 2008
While most of the reports involve multiple-dose vials, several cases include patients who received a bolus dose after their health care professional RTT News,

Vaccine Contributed to Girl's Autism Symptoms  -  Mar 6, 2008
The only childhood vaccines that contain more than trace amounts of thimerosal are multiple-dose vials of some flu vaccines. eFluxMedia

FDA Says It Approved The Wrong Drug Plant  -  Feb 18, 2008
One of its two manufacturers, Baxter International, stopped selling its multiple-dose vials of heparin earlier this month, and yesterday the FDA advised Washington Post,

US Health Officials Probe Chinese Factory's Role In Allergic ...  -  Feb 13, 2008
On February 11, the US FDA announced that Baxter has temporarily stopped the manufacturing of multiple-dose vials of Heparin due to reports of serious RTT News,

Consumer News  -  Feb 11, 2008
Baxter said it would stop manufacturing multiple-dose vials of its injectable heparin. Baxter sold 35 million vials of injectable heparin in the US last Salt Lake Tribune,

Baxter heparin now officially in short supply  -  Feb 21, 2008
Baxter temporarily stopped manufacturing multiple-dose vials of heparin earlier this month because of reports of serious allergic reactions and hypotension TheHeart.Org,

Baxter Halts Production of Blood Thinner Drug Heparin  -  Feb 12, 2008
By Anna Boyd Baxter Healthcare has temporarily stopped making its multiple-dose vials of heparin sodium following reports of serious allergic reactions and eFluxMedia

FDA Looks at Wrong Plant in China  -  Feb 18, 2008
Baxter said it would stop manufacturing multiple-dose vials while it and FDA attempts to locate the source of the problems. Baxter last month recalled nine The Associated Press

Chinese Heparin Factory Under Scrutiny  -  Feb 14, 2008
Baxter produces about half of all multiple-dose vials of heparin sold in the United States - 35 million vials. The Deerfield-based company said it has eFluxMedia

Blood Drug Shortage on the Market  -  Feb 12, 2008
It seems these situations involved only heparin produced by Baxter International Inc., so the company has now stopped the production of multiple-dose vials. Enews 2.0,

FDA tells doctors to stop use of Baxter blood thinner  -  Feb 11, 2008
Earlier in the day, Baxter said it would stop manufacturing multiple-dose vials of its injectable heparin. Baxter last month voluntarily recalled nine lots WTHI,

Baxter confirms possible irregularities in heparin  -  Feb 14, 2008
Baxter announced Monday that it had suspended manufacturing of multiple-dose vials of heparin after receiving reports of 350 bad reactions, including four Los Angeles Times,

Thursday's Health Winners & Losers  -  Feb 14, 2008
The company said on Monday that it will halt manufacturing of the multiple-dose vials while it searches for the cause of the increase in adverse reactions. TheStreet.com

China scrutinized in blood thinner problems  -  Feb 13, 2008
Baxter announced Monday that it was suspending manufacture of multiple-dose vials of heparin. The injectable drug, which is derived from pig intestines, Los Angeles Times,

US Probes Chinese Maker of Blood Thinner  -  Feb 13, 2008
This week, Baxter said it would stop manufacturing multiple-dose vials while it and FDA attempted to locate the source of the problems. The Associated Press

FDA never inspected China maker of Baxter's heparin  -  Feb 13, 2008
Baxter, which makes about half of all multiple-dose vials of heparin sold in the United States, said it has inspected the facility within the last six Reuters UK,

Local family still seeks answers in loved ones' deaths; drug ...  -  Feb 24, 2008
However, according to the FDA Web site, Baxter produces about half of the more than 1 million multiple-dose vials of heparin sold each month in the United Toledo Blade,

Widower sues drug company over heparin his wife used  -  Feb 15, 2008
According to the lawsuit, the Food and Drug Administration estimates that more than 1 million multiple-dose vials are sold each month in the United States. Toledo Blade,

Be deliberate about vaccination choices  -  Feb 23, 2008
Although all childhood vaccines are thimerosal-free, some adult and multiple-dose vials might still contain small amounts. If you still are concerned, The Olympian,

FDA Issues Heparin Warning  -  Feb 19, 2008
At this time, Baxter Healthcare Corporation has stopped manufacturing multiple-dose vials of the blood-thinning drug. And not a moment too soon. InjuryBoard.com,

Heparin Debaucle Reveals FDA Flaws  -  Feb 19, 2008
Baxter stopped selling the multiple-dose vials of heparin in early February. The reason for the reactions is still a mystery so FDA regulators are off to InjuryBoard.com,

Genetic Defect Linked to Autism, Researchers Say  -  Jan 10, 2008
The only childhood vaccines that contain more than trace amounts of thimerosal are multiple-dose vials of some flu vaccines. Researchers in Boston and eFluxMedia

Date Published: Monday, November 26th, 2007  -  Nov 26, 2007
Officials from local and state jurisdictions observed Finkelstein reusing syringes to draw up medications and dye from multiple dose vials, Newsinferno.com,

After Hepatitis Case, State Acts to Speed Alerts to Patients at Risk  -  Nov 28, 2007
...an anesthesiologist who was found to have injected patients with medicine from contaminated multiple-dose vials, that they should be tested for two New York Times,

:
 
Web health.mongabay.com/health


Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.


COPYRIGHT 2007 MONGABAY.COM